Myrexis (MYRX) Stock Price, News & Analysis

Company Overview

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.

Key Stats

• Today's Range: $0.0070 to $0.0070
• 50-Day Range: $0.0066 to $0.0070
• 52-Week Range: $0.0010 to $0.0110
• Volume: N/A
• Average Volume: 34,069 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MYRX Stock Analysis - Frequently Asked Questions

How have MYRX shares performed this year?

Myrexis' stock was trading at $0.0065 on January 1st, 2024. Since then, MYRX shares have increased by 7.7% and is now trading at $0.0070.
View the best growth stocks for 2024 here.

How do I buy shares of Myrexis?

Shares of MYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Myrexis own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Myrexis investors own include Histogenics (HSGX), Propanc Biopharma (PPCB), New Age Brands (NF), Leidos (LDOS), FSD Pharma (HUGE), Grafenia (GRA) and VAALCO Energy (EGY).

Company Calendar

• Today: 11/04/2024
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:MYRX
• CUSIP: N/A
• CIK: 1459450
• Web: www.myrexis.com
• Phone: (801) 214-7800
• Fax: 801-214-7992
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 1.45